Ideally, you should test a panel of candidate genes yourself and validate their stability across samples. There several straightforward excel applets to help with this: GeNorm, NormFinder and BestKeeper for example. Often, a combination of 2-3 genes gives the best estimate rather than using a single gene.
Take for example the study of Xiao et al.: Article Identification of reference genes in blood before and after ...
That said, you might find a study that sampled a population like your own. By serum I assume you mean excluding the leukocyte population? This could be quite heterogeneous depending on the abundance of vesicles but you might find suitable genes all the same. Probably miRNAs would be more suitable than long RNAs. There are examples of such genes in the literature, but ideally you'd like the authors' to have validated the stability of their gene(s).
It is context dependent so the most sensible advice would be to screen a panel of housekeeping genes including
Gapdh
b actin
b tubulin
b2 microglobulin
For example and any others in the lietrature that you can find where persons have demonstrated stability between treated and untreated cohorts in the context of your particualr experimental system
The issue is that in certain cells types/modes of treatment, the context itself changes the housekeeping gene, leading to innate variation between treated and untreated controls: A pre requisite is that your housekeeper unlike your GOI should not change apreciably
The only way to know for sure is to test them as described above and also take precedence from litertature in selecting the particualr genes to test